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Summary
Echinococcus spp. are cestode parasites commonly
known as small tapeworms of carnivorous animals.
Their medical importance lies in the infection of
humans by the larval stage of the parasites, predomi-
nantly including Echinococcus granulosus,w h i c hi st h e
causative agent of cystic echinococcosis (CE) and Echi-
nococcus multilocularis, which causes alveolar echino-
coccosis (AE).
A few other species or genotypes are only very rarely
o rn o ta ta l lf o u n di nh u m a n s .D u et ot h ee m e r g i n g
situation in many parts of Europe, the present article
will predominantly focus on E. multilocularis .
The natural life cycle of E. multilocularis involves pre-
dominantly red and arctic foxes as definitive hosts, but
domestic dogs can also become infected and represent
an important infection source for humans in highly
endemic areas. In the definitive host, egg production
starts as early as 28 days after infection. After egg inges-
tion by a rodent or a human, larval maturation will
occur practically exclusively within the liver tissue. The
geographic distribution of E. multilocularis is restricted
to the northern hemisphere. In Europe, relatively fre-
quent reports of AE in humans occur in central and
eastern France, Switzerland, Austria and Germany.
Within the past ten years, the endemic area of Europe
now includes many more countries such as Belgium,
The Netherlands, Italy, and most former Eastern coun-
tries as far as up to Estonia. The Asian areas where
E. multilocularis occurs include the whole zone from
the White Sea eastward to the Bering Strait, covering
large parts of Siberia, western and central parts of
China and northern Japan. Worldwide there are scant
data on the overall prevalence of human AE. Some
well-documented studies demonstrate a generally low
prevalence among affected human populations. The
annual mean incidence of new cases in different areas
including Switzerland, France, Germany and Japan has
therefore been reported to vary between 0.1 and 1.2/
100,000 inhabitants. The incidence of human cases cor-
relates with the prevalence in foxes and the fox popula-
tion density. Recently, a study documented that a four-
fold increase of the fox popu l a t i o ni nS w i t z e r l a n d
resulted in a statistically significant increase of the
annual incidence of AE cases [1] (Schweiger et al.,
2007). This dramatic increase in red fox populations has
also been reported throughout Europe, especially in
urban areas. The so-called city-fox phenomenon and,
thereafter, the increased proximity of foxes with humans
and an urban domestic dog – rodent cycle may, there-
fore, have significant public health implications [1-3].
In infected humans the E. multilocularis metacestode
(larva) develops primarily in the liver. Occasionally, sec-
ondary lesions form metastases in the lungs, brain and
other organs. The typical lesion appears macroscopically
as a dispersed mass of fibrous tissue with a conglomerate
of scattered vesiculated cavities with diameters ranging
from a few millimeters to centimeters in size. In
advanced chronic cases, a central necrotic cavity contain-
ing a viscous fluid may form, and rarely there is a bacter-
ial superinfection. The lesion often contains focal zones
of calcification, typically within the metacestode tissue.
Histologically, the hepatic lesion is characterized by a
conglomerate of small vesicles and cysts demarcated by a
thin PAS-positive laminated layer with or without an
inner germinative layer [4]. Parasite proliferation is
usually accompanied by a granulomatous host reaction,
including vigorous synthesis of fibrous and germinative
tissue in the periphery of the metacestode, but also
necrotic changes centrally. In contrast to lesions in sus-
ceptible rodent hosts, lesions from infected human
patients rarely show protoscolex formation within
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© 2010 Gottstein; licensee BioMed Central Ltd.vesicles and cysts. Genetic and immunologic host factors
are responsible for the resistance shown by some patients
in whom there is an early ‘dying out’ or ‘abortion’ of the
metacestode [5,6]. Therefore, not every individual
infected with E. multilocularis is susceptible to unlimited
metacestode proliferation and develops symptoms in the
average within 5–15 years after infection. The host
mechanisms modulating the course of infection are most
likely of an immunologic nature, including primarily sup-
pressor T cell interactions. Thus, the periparasitic granu-
loma, mainly composed of macrophages, myofibroblasts
and T cells, contains a large number of CD4+ T cells in
patients with abortive or died-out lesions, whereas in
patients with active metacestodes the number of CD8+
T cells is increased. An immunosuppressive process is
assumed to downregulate the lymphoid macrophage sys-
tem. Conversely, the status of cured AE is generally
reflected by a high in-vitro lymphoproliferative response.
T h ec y t o k i n em R N Al e v e l sf o l l o w i n gE. multilocularis
antigen stimulation of lymphocytes show an enhanced
production of Th2-cell cytokine transcripts IL-3, IL-4
and IL-10 in patients, including a significant IL-5 mRNA
expression in patients and not in healthy control donors.
A lack or deficiency of Th cell activity such as in
advanced AIDS is associated with a rapid and unlimited
growth and dissemination of the parasite in AE, recovery
of the T cell status in AIDS is prognostically favorable.
More detailed information about the host-parasite
interplay that decides about the outcome of infection
has been achieved with the murine model of AE. The
involvement of cellular immunity in controlling the
infection is strongly suggested by the intense granulo-
matous infiltration observed in the periparasitic area of
lesions. Immunodeficient athymic nude and SCID mice
exhibited high susceptibility to infection and disease,
thus suggesting that the host cell mediated immune
response plays an important role in suppressing the lar-
val growth. E. multilocularis appears to induce skewed
Th2-responses. Based on in vitro and in vivo studies,
Th2 dominated immunity was more associated with
increased susceptibility to disease, while Th1 cell activa-
tion through IL-12, IFN .g,T N F . a and IFN.a was sug-
gested to correlate with a more protective immunity in
AE. Nevertheless, effective suppression of larval growth
by means of an immunological attack is hampered by
the fact, that the parasite synthesizes a carbohydrate-
rich laminated layer in order to be protected from host
effector mechanisms, as outlined above.
Basically, the larval infection with Echinococcus multi-
locularis begins with the intrahepatic postoncospheral
development of a metacestode that – at its mature stage
- consists of an inner germinal and the outer laminated
layer as discussed above [4]. Several lines of evidence
obtained in vivo and in vitro indicate the important
bio-protective role of the laminated layer, e.g. as to
protect the germinal layer from nitric oxide produced
by periparasitic macrophages and dendritic cells, and
also to prevent immune recognition by surrounding
T cells. On the other hand, the high periparasitic NO
production by peritoneal exudate cells contributes to
periparasitic immunosuppression [7], explaining why
iNOS deficient mice exhibit a significantly lower sus-
ceptibility towards experimental infection [8]. The
intense periparasitic granulomatous infiltration indicates
an intense host-parasite interaction, and the involvement
of cellular immunity in control of the metacestode
growth kinetics is strongly suggested by experiments
carried out in T cell deficient mouse strains [9]. Carbo-
hydrate components of the laminated layer, as the Em2
(G11) and Em492 components discussed above, yield
immunomodulatory effects that allow the parasite to
survive in the host. I.e., the IgG response to the Em2
(G11)-antigen takes place independently of alpha-beta
+CD4+ T cells, and in the absence of interactions
between CD40 and CD40 ligand [10]. Such parasite
molecules also interfere with antigen presentation and
cell activation, leading to a mixed Th1/Th2-type
response at the later stage of infection. Furthermore,
Em492 [11] and other (not yet published) purified para-
site metabolites suppress ConA and antigen-stimulated
splenocyte proliferation. Infected mouse macrophages
(AE-MØ) as APCs exhibited a reduced ability to present
a conventional antigen (chicken ovalbumin, C-Ova) to
specific responder lymph node T cells when compared
to normal MØ [12].
Echinococcus granulosus parasitizes as a small tapeworm
the small intestine of dogs and occasionally other carni-
vores. The shedding of gravid proglottids or eggs in the
feces occurs within 4–6 weeks after infection of the defini-
tive host. Ingestion of eggs by intermediate host animals
or humans results in the development of a fully mature
metacestode (i.e. hydatid cyst) over a period of several
months to years. Infections with E. granulosus occur
worldwide, however predominantly in countries of South
and Central America, the European and African part of
the Mediterranean area, the Middle East and some sub-
Saharan countries, Russia and China. Most cases observed
in Central Europe and the USA are associated with immi-
grants from highly endemic areas. Various strains of
E. granulosus have been described, and differ especially in
their infectivity for intermediate hosts such as humans.
The most important strains for human infection include
sheep (G1) and cattle (G5) as intermediate hosts.
Cystic echinococcosis (CE) is clinically related to the
presence of one or more well-delineated spherical pri-
mary cysts, most frequently formed in the liver, but
other organs such as the lungs, kidney, spleen, brain,
heart and bone may be affected too. Tissue damage and
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process of space-occupying displacement of vital host
tissue, vessels or parts of organs. Consequently, clinical
manifestations are primarily determined by the site, size
and number of the cysts, and are therefore highly vari-
able. Accidental rupture of the cysts can be followed by
a massive release of cyst fluid and hematogenous or
other dissemination of protoscolices. This can result in
anaphylactic reactions and multiple secondary cystic
echinococcosis (as protoscolices can develop into sec-
ondary cysts within the same intermediate host). The
parasite evokes an immune response, which is involved
in the formation of a host-derived adventitious capsule.
This often calcifies uniquely in the periphery of the cyst,
one of the typical features found in imaging procedures.
In the liver there may be cholestasis. Commonly, there
is pressure atrophy of the surrounding parenchyma.
Immunologically, the coexistence of elevated quantities
of interferon IFN-g, IL-4, IL-5, IL-6 and IL-10 observed
in most of hydatid patients supports Th1, Th17 and
Th2 cell activation in CE. In particular, Th1 cell activa-
tion seemed to be more related to protective immunity,
whereas Th2 cell activation was related to susceptibility
to disease.
Prevention of both CE and AE focuses primarily on
veterinary interventions to control the extent and inten-
sity of infection in definitive host populations, which
may indirectly be approached by controlling the preva-
lence in animal intermediate hosts also. The first
includes regular pharmacologic treatment and taking
sanitary precautions for handling domestic dogs and to
prevent infection and egg excretion, respectively. Regu-
lar praziquantel treatment of wild-life definitive host
may contribute to lower the prevalence in affected areas.
For diagnosis, imaging procedures together with serol-
ogy will yield appropriate results [13,14]. Sonography is
t h ep r i m a r yd i a g n o s t i cp r o c e d u r eo fc h o i c ef o rh e p a t i c
cases [15], although false positives occur in up to 10% of
cases due to the presence of nonechinococcal serous
cysts, abscesses or tumors. Computerized tomography is
the best investigation for detecting extrahepatic disease
and volumetric follow-up assessment; magnetic reso-
nance imaging (MRI) assists in the diagnosis by identify-
ing changes in the intra- and extrahepatic venous
systems. Ultrasonography is also helpful in following up
treated patients as successfully treated cysts become
hyperechogenic. Calcification of variable degree occurs
in about 10% of the cysts. Aspiration cytology appears
to be particularly helpful in the detection of pulmonary,
renal and other nonhepatic lesions for which imaging
techniques and serology do not provide appropriate
diagnostic support. The viability of aspirated protosco-
lices can be determined by microscopic demonstration
of flame cell activity and trypan blue dye exclusion.
Immunodiagnostic tests to detect serum antibodies are
used to support the clinical diagnosis of both AE and
CE.
Assessing the parasite viability in vitro following thera-
peutic interventions may be of tremendous advantage
when compared with the invasive analysis of resected or
biopsied samples. Such alternatives may be offered by
magnetic resonance spectrometry or positron emission
tomography (PET). The latter technique has recently been
used for assessing the efficacy of chemotherapy in AE.
PET positivity actually demonstrates periparasitic inflam-
matory processes due to a remaing activity of the metaces-
tode tissue. Serologic test sa r em o r er e l i a b l ei nt h e
diagnosis of AE than CE. The use of purified E. multilocu-
laris antigens such as the Em2 antigen and recombinant
antigens from the family of EMR-proteins (EmII/3-10,
EM10, EM4 and Em18, all four of them harbouring an
identical immunodominant oligopeptide sequence) exhi-
bits diagnostic sensitivities ranging between 91% and
100%, with overall specificities of 98–100%. These antigens
allow discrimination between the alveolar and the cystic
forms of disease with a reliability of 95%. Seroepidemiolo-
gic studies reveal asymptomatic preclinical cases of human
AE as well as cases in which the metacestode has died at
an apparently early stage of infection (see above). Serologic
tests are of value for assessing the efficacy of treatment
and chemotherapy only when linked to appropriate ima-
ging investigations. Prognostically, disappearance of anti-
II/3–10 or anti-Em18 antibody levels coupled to PET
negativity indicates innactivation of AE. The management
of CE and AE follows the strategy recommended in the
manual on echinococcosis published in 2001 by the Office
International des Epizooties and the World Health
Organisation.
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